Mallinckrodt shares trading lower likely on continued profit taking following a 90% rally on Tuesday. Despite also paring gains on Wednesday, the stock is still up about 43% since announcing it will sell BioVectra to HIG Capital for $250 million.
Benzinga Newsdesk